Malignant neoplasm of posterior wall of hypopharynx
ICD-10 C13.2 is a billable code used to indicate a diagnosis of malignant neoplasm of posterior wall of hypopharynx.
C13.2 refers to a malignant neoplasm located specifically in the posterior wall of the hypopharynx, which is the part of the throat situated behind the larynx and above the esophagus. This type of cancer is often associated with risk factors such as tobacco use, heavy alcohol consumption, and human papillomavirus (HPV) infection. The hypopharynx is a critical area for swallowing and speech, and malignancies here can lead to significant morbidity. Symptoms may include dysphagia (difficulty swallowing), odynophagia (painful swallowing), hoarseness, and a lump in the neck. Diagnosis typically involves imaging studies such as CT or MRI scans, and biopsy for histological confirmation. Treatment often includes a combination of surgery, radiation therapy, and chemotherapy, depending on the stage and location of the tumor. HPV status is increasingly recognized as a significant prognostic factor, particularly in oropharyngeal cancers, influencing treatment decisions and outcomes.
Detailed pathology reports, imaging studies, and treatment plans must be documented.
Patients presenting with dysphagia or neck masses, requiring biopsy and staging.
HPV testing results should be clearly documented as they influence treatment and prognosis.
Thorough examination notes, imaging results, and surgical reports are essential.
Patients undergoing surgical resection of hypopharyngeal tumors.
Documentation must include details on the extent of resection and any reconstructive procedures performed.
Used for initial evaluation of suspected hypopharyngeal malignancy.
Document findings and any biopsies taken.
Otolaryngologists should ensure thorough documentation of the procedure.
HPV status is crucial as it can influence treatment decisions and prognosis. HPV-positive tumors often have a better response to treatment and improved survival rates compared to HPV-negative tumors.